PMID- 26440518 OWN - NLM STAT- MEDLINE DCOM- 20160429 LR - 20190202 IS - 1553-7374 (Electronic) IS - 1553-7366 (Print) IS - 1553-7366 (Linking) VI - 11 IP - 10 DP - 2015 Oct TI - BCG Skin Infection Triggers IL-1R-MyD88-Dependent Migration of EpCAMlow CD11bhigh Skin Dendritic cells to Draining Lymph Node During CD4+ T-Cell Priming. PG - e1005206 LID - 10.1371/journal.ppat.1005206 [doi] LID - e1005206 AB - The transport of antigen from the periphery to the draining lymph node (DLN) is critical for T-cell priming but remains poorly studied during infection with Mycobacterium bovis Bacille Calmette-Guerin (BCG). To address this we employed a mouse model to track the traffic of Dendritic cells (DCs) and mycobacteria from the BCG inoculation site in the skin to the DLN. Detection of BCG in the DLN was concomitant with the priming of antigen-specific CD4+ T cells at that site. We found EpCAMlow CD11bhigh migratory skin DCs to be mobilized during the transport of BCG to the DLN. Migratory skin DCs distributed to the T-cell area of the LN, co-localized with BCG and were found in close apposition to antigen-specific CD4+ T cells. Consequently, blockade of skin DC traffic into DLN dramatically reduced mycobacterial entry into DLN and muted T-cell priming. Interestingly, DC and mycobacterial entry into the DLN was dependent on IL-1R-I, MyD88, TNFR-I and IL-12p40. In addition, we found using DC adoptive transfers that the requirement for MyD88 in BCG-triggered migration was not restricted to the migrating DC itself and that hematopoietic expression of MyD88 was needed in part for full-fledged migration. Our observations thus identify a population of DCs that contribute towards the priming of CD4+ T cells to BCG infection by transporting bacilli into the DLN in an IL-1R-MyD88-dependent manner and reveal both DC-intrinsic and -extrinsic requirements for MyD88 in DC migration. FAU - Bollampalli, Vishnu Priya AU - Bollampalli VP AD - Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. FAU - Harumi Yamashiro, Livia AU - Harumi Yamashiro L AD - Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Department of Pharmacology, Federal University of Santa Catarina, Florianopolis, Brazil. FAU - Feng, Xiaogang AU - Feng X AD - Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. FAU - Bierschenk, Damien AU - Bierschenk D AD - Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. FAU - Gao, Yu AU - Gao Y AD - Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. FAU - Blom, Hans AU - Blom H AD - Science for Life Laboratory, Royal Institute of Technology, Stockholm, Sweden. FAU - Henriques-Normark, Birgitta AU - Henriques-Normark B AD - Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. FAU - Nylen, Susanne AU - Nylen S AD - Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. FAU - Rothfuchs, Antonio Gigliotti AU - Rothfuchs AG AD - Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20151006 PL - United States TA - PLoS Pathog JT - PLoS pathogens JID - 101238921 RN - 0 (BCG Vaccine) RN - 0 (Myd88 protein, mouse) RN - 0 (Myeloid Differentiation Factor 88) RN - 0 (Receptors, Interleukin-1) SB - IM MH - Animals MH - BCG Vaccine/*immunology MH - CD4-Positive T-Lymphocytes/*immunology MH - Cell Movement/immunology MH - Dendritic Cells/*immunology/metabolism/microbiology MH - Disease Models, Animal MH - Flow Cytometry MH - Lymph Nodes/*immunology MH - Lymphocyte Activation/*immunology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Microscopy, Confocal MH - Mycobacterium bovis/immunology MH - Myeloid Differentiation Factor 88/immunology MH - Real-Time Polymerase Chain Reaction MH - Receptors, Interleukin-1/immunology MH - Skin/immunology/microbiology MH - Tuberculosis/immunology/prevention & control PMC - PMC4594926 COIS- The authors have declared that no competing interests exist. EDAT- 2015/10/07 06:00 MHDA- 2016/04/30 06:00 PMCR- 2015/10/06 CRDT- 2015/10/07 06:00 PHST- 2015/04/07 00:00 [received] PHST- 2015/09/14 00:00 [accepted] PHST- 2015/10/07 06:00 [entrez] PHST- 2015/10/07 06:00 [pubmed] PHST- 2016/04/30 06:00 [medline] PHST- 2015/10/06 00:00 [pmc-release] AID - PPATHOGENS-D-15-00825 [pii] AID - 10.1371/journal.ppat.1005206 [doi] PST - epublish SO - PLoS Pathog. 2015 Oct 6;11(10):e1005206. doi: 10.1371/journal.ppat.1005206. eCollection 2015 Oct.